Biovac, Sanofi Pasteur to Make Pediatric Vaccine in South Africa

Biovac, South Africa’s state vaccine company, will manufacture the Hexaxim vaccine under license from Sanofi Pasteur, marking the first manufacture of vaccines in the country since the mid 1990s.

The vaccine protects against six common diseases affecting infants, the companies said in a statement on Thursday.

©2020 Bloomberg L.P.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.